1. Home
  2. AVXL vs TDF Comparison

AVXL vs TDF Comparison

Compare AVXL & TDF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Anavex Life Sciences Corp.

AVXL

Anavex Life Sciences Corp.

N/A

Current Price

$2.44

Market Cap

237.2M

Sector

Health Care

ML Signal

N/A

Logo Templeton Dragon Fund Inc.

TDF

Templeton Dragon Fund Inc.

N/A

Current Price

$10.26

Market Cap

268.9M

Sector

Finance

ML Signal

N/A

Company Overview

Basic Information
Metric
AVXL
TDF
Founded
2004
1994
Country
United States
Singapore
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Finance/Investors Services
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
237.2M
268.9M
IPO Year
2013
N/A

Fundamental Metrics

Financial Performance
Metric
AVXL
TDF
Price
$2.44
$10.26
Analyst Decision
Strong Buy
Analyst Count
3
0
Target Price
$22.00
N/A
AVG Volume (30 Days)
677.9K
37.3K
Earning Date
05-08-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.26
$10.26
52 Week High
$10.38
$12.20

Technical Indicators

Market Signals
Indicator
AVXL
TDF
Relative Strength Index (RSI) 38.03 35.02
Support Level $2.33 $10.36
Resistance Level $2.80 $11.33
Average True Range (ATR) 0.16 0.17
MACD -0.07 -0.05
Stochastic Oscillator 4.42 20.83

Price Performance

Historical Comparison
AVXL
TDF

About AVXL Anavex Life Sciences Corp.

Anavex Life Sciences Corp is a clinical stage biopharmaceutical company engaged in the development of differentiated therapeutics by applying precision medicine to central nervous system(CNS) diseases with high unmet need. It analyzes genomic data from clinical trials to identify biomarkers, which are used in the analysis of its clinical trials for the treatment of neurodegenerative and neurodevelopmental diseases. The company focuses on developing treatments for Alzheimer's disease, Parkinson's disease, schizophrenia, neurodevelopmental, neurodegenerative, and rare diseases, including Rett syndrome, and other central nervous system (CNS) disorders. Its pipeline includes ANAVEX 2-73 and ANAVEX 3-71 and several other compounds in different stages of clinical and pre-clinical development.

About TDF Templeton Dragon Fund Inc.

Templeton Dragon Fund Inc is a closed-end management investment company. The fund seeks long-term capital appreciation by investing majority of its total assets in equity securities of China companies. It invest in various sectors such as gas & consumable fuels, auto components, banks, beverages, communications equipment, healthcare equipment & supplies, restaurants & leisure, household durables and many others.

Share on Social Networks: